Form 4: MindMed CEO Robert Barrow Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
MindMed's CEO, Robert Barrow, sold 21,208 common shares on March 25, 2025, to cover withholding tax obligations related to vested restricted stock units.
Summary
- Robert Barrow, the CEO of Mind Medicine (MindMed) Inc., sold 21,208 common shares on March 25, 2025.
- The sale was executed to satisfy withholding tax obligations related to the settlement of vested restricted stock units.
- The shares were sold at a weighted average price of $6.74, with individual transactions ranging from $6.67 to $6.79.
- Following the transaction, Barrow beneficially owns 856,556 common shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes and doesn't indicate a change in the company's fundamentals.
Industry Context
This is a routine Form 4 filing related to insider transactions. It is common for executives to sell shares to cover tax obligations related to stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| June 15, 2022 | Date of adoption of the Rule 10b5-1 plan. |
| March 25, 2025 | Date of the share sale transaction. |
Keywords
MindMed, Robert Barrow, share sale, Form 4, insider trading, restricted stock units, tax obligations, MNMD
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.